|
Laboratory investigations
|
Patients without risk factors (A1) (n = 37)
|
Patients with risk factors (A2) (n = 23)
|
Healthy controls (n = 60)
|
Test value
|
p-value
|
Post hoc between A1 and A2
|
|---|
|
RBS (mg/dl)
|
Mean ± SD
|
115.6 ± 52.7
|
145.6 ± 87.2
|
110.1 ± 28
|
F = 3.98
|
0.02*
|
0.049*
|
|
Range
|
81–218
|
75–379
|
74–188
|
|
Creatinine (mg/dl)
|
Mean ± SD
|
0. 74 ± 0.2
|
0.88 ± 0.2
|
0.59 ± 1.6
|
F = 12.2
|
< 0.001*
|
0.02*
|
|
Range
|
0.3–1.2
|
0.5–2
|
0.3–1
|
|
Total cholesterol (mg/dl)
|
Mean ± SD
|
174.2 ± 38.7
|
194.1 ± 49.9
|
138.8 ± 52.2
|
F = 12.7
|
< 0.001*
|
0.28
|
|
Range
|
93–224
|
103–313
|
55–215
|
|
TG (mg/dl)
|
Mean ± SD
|
125.4 ± 51.7
|
165.8 ± 82.5
|
98.3 ± 31.9
|
F = 14.3
|
< 0.001*
|
0.01*
|
|
Range
|
47–262
|
66–324
|
54–201
|
|
LDL (mg/dl)
|
Mean ± SD
|
110.5 ± 36.6
|
124.2 ± 48.3
|
95.1 ± 27.6
|
F = 6.1
|
0.003*
|
0.35
|
|
Range
|
39–224
|
51–233
|
45–164
|
|
HDL (mg/dl)
|
Mean ± SD
|
35.5 ± 8.7
|
36.9 ± 7.9
|
32.7 ± 8.7
|
F = 2.37
|
0.098
|
0.83
|
|
Range
|
13–54
|
25–60
|
12–51
|
- *One-way ANOVA (analysis of variance) is statistically significant at level of significance of 95%. (p < 0.05). RBS random blood sugar, TG triglycerides, LDL low-density lipoprotein, HDL high-density lipoprotein
- bold indicates statistically significant relation
- italic indicates the type of the test used
